145 related articles for article (PubMed ID: 20412115)
1. Refining the phenotype associated with MEF2C haploinsufficiency.
Novara F; Beri S; Giorda R; Ortibus E; Nageshappa S; Darra F; Dalla Bernardina B; Zuffardi O; Van Esch H
Clin Genet; 2010 Nov; 78(5):471-7. PubMed ID: 20412115
[TBL] [Abstract][Full Text] [Related]
2. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
Zweier M; Gregor A; Zweier C; Engels H; Sticht H; Wohlleber E; Bijlsma EK; Holder SE; Zenker M; Rossier E; Grasshoff U; Johnson DS; Robertson L; Firth HV; ; Ekici AB; Reis A; Rauch A
Hum Mutat; 2010 Jun; 31(6):722-33. PubMed ID: 20513142
[TBL] [Abstract][Full Text] [Related]
3. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
Le Meur N; Holder-Espinasse M; Jaillard S; Goldenberg A; Joriot S; Amati-Bonneau P; Guichet A; Barth M; Charollais A; Journel H; Auvin S; Boucher C; Kerckaert JP; David V; Manouvrier-Hanu S; Saugier-Veber P; Frébourg T; Dubourg C; Andrieux J; Bonneau D
J Med Genet; 2010 Jan; 47(1):22-9. PubMed ID: 19592390
[TBL] [Abstract][Full Text] [Related]
4. 5q14.3 neurocutaneous syndrome: a novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C.
Carr CW; Zimmerman HH; Martin CL; Vikkula M; Byrd AC; Abdul-Rahman OA
Am J Med Genet A; 2011 Jul; 155A(7):1640-5. PubMed ID: 21626678
[TBL] [Abstract][Full Text] [Related]
5. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C.
Nowakowska BA; Obersztyn E; Szymańska K; Bekiesińska-Figatowska M; Xia Z; Ricks CB; Bocian E; Stockton DW; Szczałuba K; Nawara M; Patel A; Scott DA; Cheung SW; Bohan TP; Stankiewicz P
Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):1042-51. PubMed ID: 20333642
[TBL] [Abstract][Full Text] [Related]
6. Refining the phenotype associated with MEF2C point mutations.
Bienvenu T; Diebold B; Chelly J; Isidor B
Neurogenetics; 2013 Feb; 14(1):71-5. PubMed ID: 23001426
[TBL] [Abstract][Full Text] [Related]
7. Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.
Kleefstra T; van Zelst-Stams WA; Nillesen WM; Cormier-Daire V; Houge G; Foulds N; van Dooren M; Willemsen MH; Pfundt R; Turner A; Wilson M; McGaughran J; Rauch A; Zenker M; Adam MP; Innes M; Davies C; López AG; Casalone R; Weber A; Brueton LA; Navarro AD; Bralo MP; Venselaar H; Stegmann SP; Yntema HG; van Bokhoven H; Brunner HG
J Med Genet; 2009 Sep; 46(9):598-606. PubMed ID: 19264732
[TBL] [Abstract][Full Text] [Related]
8. Interstitial deletion 5q14.3q21.3 with MEF2C haploinsufficiency and mild phenotype: when more is less.
Tonk V; Kyhm JH; Gibson CE; Wilson GN
Am J Med Genet A; 2011 Jun; 155A(6):1437-41. PubMed ID: 21567930
[TBL] [Abstract][Full Text] [Related]
9. MEF2C mutations are a rare cause of Rett or severe Rett-like encephalopathies.
Lambert L; Bienvenu T; Allou L; Valduga M; Echenne B; Diebold B; Mignot C; Héron D; Roth V; Saunier A; Moustaïne A; Jonveaux P; Philippe C
Clin Genet; 2012 Nov; 82(5):499-501. PubMed ID: 22449245
[No Abstract] [Full Text] [Related]
10. De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum.
Shimojima K; Okumura A; Mori H; Abe S; Ikeno M; Shimizu T; Yamamoto T
Am J Med Genet A; 2012 Sep; 158A(9):2272-6. PubMed ID: 22848023
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy.
Ceulemans BP; Claes LR; Lagae LG
Pediatr Neurol; 2004 Apr; 30(4):236-43. PubMed ID: 15087100
[TBL] [Abstract][Full Text] [Related]
12. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes.
Bruno DL; Anderlid BM; Lindstrand A; van Ravenswaaij-Arts C; Ganesamoorthy D; Lundin J; Martin CL; Douglas J; Nowak C; Adam MP; Kooy RF; Van der Aa N; Reyniers E; Vandeweyer G; Stolte-Dijkstra I; Dijkhuizen T; Yeung A; Delatycki M; Borgström B; Thelin L; Cardoso C; van Bon B; Pfundt R; de Vries BB; Wallin A; Amor DJ; James PA; Slater HR; Schoumans J
J Med Genet; 2010 May; 47(5):299-311. PubMed ID: 20452996
[TBL] [Abstract][Full Text] [Related]
13. ADGRV1 is implicated in myoclonic epilepsy.
Myers KA; Nasioulas S; Boys A; McMahon JM; Slater H; Lockhart P; Sart DD; Scheffer IE
Epilepsia; 2018 Feb; 59(2):381-388. PubMed ID: 29266188
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder.
Fernandez BA; Roberts W; Chung B; Weksberg R; Meyn S; Szatmari P; Joseph-George AM; Mackay S; Whitten K; Noble B; Vardy C; Crosbie V; Luscombe S; Tucker E; Turner L; Marshall CR; Scherer SW
J Med Genet; 2010 Mar; 47(3):195-203. PubMed ID: 19755429
[TBL] [Abstract][Full Text] [Related]
15. Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions.
Béri-Dexheimer M; Latger-Cannard V; Philippe C; Bonnet C; Chambon P; Roth V; Grégoire MJ; Bordigoni P; Lecompte T; Leheup B; Jonveaux P
Eur J Hum Genet; 2008 Aug; 16(8):1014-8. PubMed ID: 18478040
[TBL] [Abstract][Full Text] [Related]
16. De novo 5q14.3 translocation 121.5-kb upstream of MEF2C in a patient with severe intellectual disability and early-onset epileptic encephalopathy.
Saitsu H; Igarashi N; Kato M; Okada I; Kosho T; Shimokawa O; Sasaki Y; Nishiyama K; Tsurusaki Y; Doi H; Miyake N; Harada N; Hayasaka K; Matasumoto N
Am J Med Genet A; 2011 Nov; 155A(11):2879-84. PubMed ID: 21990267
[TBL] [Abstract][Full Text] [Related]
17. MEF2C deletions and mutations versus duplications: a clinical comparison.
Novara F; Rizzo A; Bedini G; Girgenti V; Esposito S; Pantaleoni C; Ciccone R; Sciacca FL; Achille V; Della Mina E; Gana S; Zuffardi O; Estienne M
Eur J Med Genet; 2013 May; 56(5):260-5. PubMed ID: 23402836
[TBL] [Abstract][Full Text] [Related]
18. Balanced translocation in a patient with severe myoclonic epilepsy of infancy disrupts the sodium channel gene SCN1A.
Møller RS; Schneider LM; Hansen CP; Bugge M; Ullmann R; Tommerup N; Tümer Z
Epilepsia; 2008 Jun; 49(6):1091-4. PubMed ID: 18294202
[TBL] [Abstract][Full Text] [Related]
19. SCN1A mutation associated with intractable myoclonic epilepsy and migraine headache.
Frosk P; Mhanni AA; Rafay MF
J Child Neurol; 2013 Mar; 28(3):389-91. PubMed ID: 22550089
[TBL] [Abstract][Full Text] [Related]
20. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders.
Mikhail FM; Lose EJ; Robin NH; Descartes MD; Rutledge KD; Rutledge SL; Korf BR; Carroll AJ
Am J Med Genet A; 2011 Oct; 155A(10):2386-96. PubMed ID: 22031302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
